 |
| Abstract Details |
 |
||
|
||
| Abstract Title: | ||
|
||
| Endpoints for validation of tumor markers for recurrence risk: Recurrence-free interval (RFI), disease-free survival (DFS), overall survival (OS), and colon-cancer specific survival (CCSS) in CALGB 9581. | ||
|
||
| Author: | ||
|
||
| Najjia N. Mahmoud, Rita Lopatin, Kim Clark-Langone, Mark Lee, Donna Niedzwiecki, Alan P. Venook | ||
|
||